CFO
CORZ icon

Custos Family Office’s Core Scientific CORZ Stock Holding History

Custos Family Office’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.1M Hold
121,306
– – 1.86% 14
2026
Q1 		$1.81M Hold
121,306
– – 1.26% 16
2025
Q4 		$1.77M Hold
121,306
– – 1.21% 16
2025
Q3 		$2.18M Hold
121,306
– – 1.23% 16
2025
Q2 		$2.07M Hold
121,306
– – 0.66% 25
2025
Q1 		$878K Buy
121,306
+69,060
+132% +$786K 0.31% 34
2024
Q4 		$734K Hold
52,246
– – 0.26% 37
2024
Q3 		$620K Hold
52,246
– – 0.22% 37
2024
Q2 		$486K Buy
+52,246
New +$267K 0.19% 40

Other funds holding CORZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SA
Situational Awareness San Francisco, California $20.2B AUM 612.59% 1-Year Est. Return
JCAM
Jericho Capital Asset Management New York $12.1B AUM 109.57% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VARA
Value Aligned Research Advisors Princeton, New Jersey $40.1B AUM 376.19% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return

Custos Family Office's CORZ Position: Q2 2026 in Review

Custos Family Office held its Core Scientific (CORZ) position steady in Q2 2026 at 121,306 shares worth $3.1M. The position accounts for 1.86% of the portfolio, ranked #14.

Custos Family Office first reported a position in CORZ in Q2 2024 and has held it in 9 quarters since. 412 funds tracked by Wall St. Rank hold CORZ as of Q2 2026.

  • Custos Family Office held 121,306 shares of Core Scientific worth $3.1M as of Q2 2026.
  • Custos Family Office left its Core Scientific share count unchanged in Q2 2026.
  • Core Scientific made up 1.86% of Custos Family Office's portfolio in Q2 2026, its #14 holding.
  • Custos Family Office first reported a position in Core Scientific in Q2 2024 and has held it in 9 quarters since.
  • 412 funds tracked by Wall St. Rank held Core Scientific as of Q2 2026.

Based on Custos Family Office's 13F filing for Q2 2026, filed 19 Aug 2026.